AR088470A1 - Un compuesto para el tratamiento de la hepatitis c - Google Patents
Un compuesto para el tratamiento de la hepatitis cInfo
- Publication number
- AR088470A1 AR088470A1 ARP120103927A ARP120103927A AR088470A1 AR 088470 A1 AR088470 A1 AR 088470A1 AR P120103927 A ARP120103927 A AR P120103927A AR P120103927 A ARP120103927 A AR P120103927A AR 088470 A1 AR088470 A1 AR 088470A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- treatment
- hepatitis
- hcv
- tetrahydrocyclopropa
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Abstract
(1aR,12bS)-8-ciclohexil-11-fluoro-N-((1-metilciclopropil)sulfonil)-1a-((3-metil-3,8-diazabiciclo[3.2.1]oct-8-il)carbonil)-1,1a,2,12b-tetrahidrociclopropa[d]indolo[2,1-a][2]benzazepin-5-carboxamida de fórmula (1), que incluye las sales aceptables desde el punto de vista farmacéutico, y las composiciones y los métodos de uso del compuesto. El compuesto tiene actividad contra el virus de la hepatitis C (HCV) y puede ser útil para el tratamiento de las personas infectadas por HCV.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161549450P | 2011-10-20 | 2011-10-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR088470A1 true AR088470A1 (es) | 2014-06-11 |
Family
ID=47144132
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP120103927A AR088470A1 (es) | 2011-10-20 | 2012-10-19 | Un compuesto para el tratamiento de la hepatitis c |
Country Status (10)
Country | Link |
---|---|
US (1) | US8716275B2 (es) |
EP (1) | EP2768831B1 (es) |
JP (1) | JP2014530860A (es) |
CN (1) | CN104203949B (es) |
AR (1) | AR088470A1 (es) |
ES (1) | ES2559295T3 (es) |
IN (1) | IN2014CN02807A (es) |
TW (1) | TW201323426A (es) |
UY (1) | UY34400A (es) |
WO (1) | WO2013059265A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2792360A1 (en) | 2013-04-18 | 2014-10-22 | IP Gesellschaft für Management mbH | (1aR,12bS)-8-cyclohexyl-11-fluoro-N-((1-methylcyclopropyl)sulfonyl)-1a-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-1,1a,2,2b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide for use in treating HCV |
ES2702910T3 (es) | 2013-07-31 | 2019-03-06 | Happiest Baby Inc | Dispositivo para calma de bebés |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7348425B2 (en) * | 2004-08-09 | 2008-03-25 | Bristol-Myers Squibb Company | Inhibitors of HCV replication |
US7399758B2 (en) | 2005-09-12 | 2008-07-15 | Meanwell Nicholas A | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
WO2007092000A1 (en) * | 2006-02-06 | 2007-08-16 | Bristol-Myers Squibb Company | Inhibitors of hcv replication |
US7456166B2 (en) * | 2006-05-17 | 2008-11-25 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
CN101443336B (zh) * | 2006-05-17 | 2012-07-04 | 百时美施贵宝公司 | 环丙基稠合的[吲哚]并[苯并氮杂*]hcv ns5b抑制剂 |
US7547690B2 (en) * | 2007-03-14 | 2009-06-16 | Bristol-Myers Squibb Company | Compounds for the treatment of Hepatitis C |
US8129367B2 (en) * | 2007-11-21 | 2012-03-06 | Bristol-Myers Squibb Company | Compounds for the treatment of Hepatitis C |
TWI454476B (zh) * | 2008-07-08 | 2014-10-01 | Tibotec Pharm Ltd | 用作c型肝炎病毒抑制劑之巨環吲哚衍生物 |
-
2012
- 2012-10-15 US US13/651,538 patent/US8716275B2/en active Active
- 2012-10-17 JP JP2014537163A patent/JP2014530860A/ja active Pending
- 2012-10-17 IN IN2807CHN2014 patent/IN2014CN02807A/en unknown
- 2012-10-17 CN CN201280063620.9A patent/CN104203949B/zh not_active Expired - Fee Related
- 2012-10-17 WO PCT/US2012/060537 patent/WO2013059265A1/en active Application Filing
- 2012-10-17 ES ES12783457.0T patent/ES2559295T3/es active Active
- 2012-10-17 EP EP12783457.0A patent/EP2768831B1/en not_active Not-in-force
- 2012-10-19 AR ARP120103927A patent/AR088470A1/es unknown
- 2012-10-19 TW TW101138801A patent/TW201323426A/zh unknown
- 2012-10-19 UY UY0001034400A patent/UY34400A/es unknown
Also Published As
Publication number | Publication date |
---|---|
CN104203949B (zh) | 2016-06-22 |
US20130102589A1 (en) | 2013-04-25 |
ES2559295T3 (es) | 2016-02-11 |
JP2014530860A (ja) | 2014-11-20 |
UY34400A (es) | 2013-05-31 |
CN104203949A (zh) | 2014-12-10 |
IN2014CN02807A (es) | 2015-07-03 |
EP2768831B1 (en) | 2015-11-25 |
WO2013059265A1 (en) | 2013-04-25 |
US8716275B2 (en) | 2014-05-06 |
TW201323426A (zh) | 2013-06-16 |
EP2768831A1 (en) | 2014-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP15000435A (es) | Inhibidores macrocíclicos de virus flaviviridae | |
AR106037A1 (es) | Moduladores de la proteína core de la hepatitis b | |
GT201500086A (es) | Análogos de 2'-cloro nucleósido para infección por vhc | |
EA201492209A1 (ru) | Макроциклические ингибиторы вирусов flaviviridae | |
CO6561783A2 (es) | Inhibidores del virus flaviviridae | |
CL2013003019A1 (es) | Compuestos derivados de benzotiazol; composicion farmaceutica que los comprende; y su uso en el tratamiento del vih. | |
GT201500020A (es) | Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de la hepatitis b | |
UY35362A (es) | Compuestos terapéuticos | |
ECSP12011684A (es) | Inhibidores de los virus flaviviridae. | |
UY32462A (es) | Derivados de bifenilo novedosos para el tratamiento de infección por virus de hepatitis c 644 | |
UY36465A (es) | Compuestos policíclicos de carbamoilpiridona y su uso farmacéutico | |
IN2014MN02658A (es) | ||
EA201390822A1 (ru) | Макроциклические ингибиторы вирусов flaviviridae | |
CL2013003313A1 (es) | Compuestos derivados de 2,4-diaminoquinazolinas, sales o solvatos farmacéuticamente aceptables; composición farmacéutica que los comprende; y uso en el tratamiento de un trastorno en el que interviene la modulación de tlr7 y/o tlr8. | |
ECSP12012104A (es) | Inhibidores de virus flaviviridae | |
CL2013002650A1 (es) | Compuestos derivados triciclicos con actividad sobre los receptores hormonales nucleares; composicion farmaceutica que los comprende; proceso de reparacion de compuestos intermediarios; y uso en el tratamiento del sida, insuficiencia adrenal aguda, enfermedad de addison, rinitis alergica, enfermedad de alzheimer, entre otros. | |
EA201790661A3 (ru) | Ингибиторы вируса гепатита c | |
CL2013003229A1 (es) | Compuestos inhibidores del virus de la hepatitis c (vhc); composicion farmaceutica que los comprende; y uso en el tratamiento de una infeccion por vhc. | |
CL2014001016A1 (es) | Compuestos triciclicos condensados y sus sales farmaceuticamente aceptables; composicion farmaceutica que los comprende; y su uso en el tratamiento de una infeccion viral. | |
CL2014001047A1 (es) | Compuestos heterociclicos derivados de pirazina; composicion y combinacion farmaceutica que los contienen y el uso en enfermedades respiratorias y alergicas. | |
RS55592B1 (sr) | 9-metil supstituisani heksadekahidrociklopropa(e)pirolo(1,2-a)(1,4)diazaciklopentadecinil karbamat derivati kao nestrukturalni 3 (ns3) proteazni inhibitori za lečenje infekcijavirusom hepatitisa c | |
CL2016000300A1 (es) | Métodos terapéuticos | |
WO2014116772A3 (en) | Squaric derivatives for the treatment of hepatitis c | |
AR088470A1 (es) | Un compuesto para el tratamiento de la hepatitis c | |
UY35390A (es) | Compuestos con actividad anti-hcv y composiciones farmacéuticas que los contienen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |